Ruben Tommasi Email

Chief Scientific Officer . Dunad Therapeutics

Cambridge, Cambridge

Location

Current Roles

Employees:
35
Revenue:
$2.7M
About
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted oral protein degradation therapies. Dunad’s platform enables selective degradation via direct target modification using tunable mono-valent small molecules, allowing for the development of more drug-like, orally bioavailable and CNS-accessible protein degraders.
Dunad Therapeutics Address
125 Old Broad Street
Cambridge, Cambridge
Dunad Therapeutics Email

Past Companies

Dunad TherapeuticsChief Scientific Officer
Entasis TherapeuticsChief Scientific Officer
AstraZenecaExecutive Director - Infection Chemistry

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.